Orlistat CAS 96829-58-2 Potent Pancreatic Lipase Inhibitor for Obesity and Metabolic hfd
TDS 6 Inquiries
96829-58-2
Reagent Grade
99%
qingdao
//
5g, 25g, 100g, 500g
2026-09-30
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceOrlistat is a lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats.
Solid
Orlistat is a carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug. It has a role as an EC 3.1.1.3 (triacylglycerol lipase) inhibitor, a bacterial metabolite, an EC 2.3.1.85 (fatty acid synthase) inhibitor and an anti-obesity agent. It is a beta-lactone, a L-leucine derivative, a member of formamides and a carboxylic ester.|Orlistat is a drug used in the treatment of obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Orlistat works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.|Orlistat is an Intestinal Lipase Inhibitor. The mechanism of action of orlistat is as a Lipase Inhibitor.|Orlistat is an inhibitor of pancreatic and gastric lipase and a commonly used weight loss agent that is available both by prescription and over-the-counter. Orlistat has been linked to rare instances of acute liver injury, some of which have been severe.|Orlistat is a reversible active-site inhibitor of gastrointestinal lipases. Orlistat forms a covalent bond with the active serine site in gastric and pancreatic lipases, thereby inhibiting their activity and preventing dietary fat from being hydrolyzed and absorbed. (NCI04)|A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.Certificates-
TDS
Basic Info-
Product Name:
Tetrahydrolipstatin
Other Name:L-Leucine,N-formyl-,(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;L-Leucine,N-formyl-,1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester,[2S-[2α(R*),3β]]-;Tetrahydrolipstatin;(-)-Tetrahydrolipstatin;Ro 18-0647/002;Orlistat;Xenical;Listata;Alli;111397-16-1;1236363-36-2
CAS No.:96829-58-2
Molecular Formula:C29H53NO5
InChIKeys:InChIKey=AHLBNYSZXLDEJQ-FWEHEUNISA-N
Molecular Weight:495.73500
Exact Mass:495.73
UNII:95M8R751W8
DSSTox ID:DTXSID8023395
NCI Thesaurus Code:C29303
Color/Form:Crystals
ATC Code:A08AB01|A - Alimentary tract and metabolism
HScode:29322090
Categories:
Characteristics-
PSA:
81.70000
XLogP3:10
Appearance:Solid
Density:0.976 g/cm3
Melting Point:39-41 °C
Boiling Point:615.9ºC at 760 mmHg
Flash Point:326.3ºC
Refractive Index:1.469
Water Solubility:Practically insoluble in water
Storage Conditions:2-8ºC
Vapor Pressure:9.77X10-14 mm Hg at 25 deg C (est)
Specific rotation:Specific optical rotation at 20 °C: -32.0 deg ( c = 1 in chloroform)
Henrys Law Constant:Henry's Law constant = 1.13X10-9 atm-cu m/mole at 25 °C (est)
Dissociation Constants:Orlistat has no pKa within the physiological range
Collision Cross Section:241.2 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Experimental Properties:Hydroxyl radical reaction rate constant = 4.52x10-13 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 3
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) H412 Harmful to aquatic life with long lasting effects
Precautionary statement(s) Prevention P273 Avoid release to the environment.
Response none
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
United Arab Emirates
orlistat
1000 KG Feb 25, 2025
Malaysia
Orlistat 99% powder C29H53NO5 factory price safety delivery likes
1 KG Oct 19, 2023
Netherlands
Factory hot sale Orlistat Pure Raw Steroid Powder
100 G Apr 11, 2025
United States
Orlistat
1 KG Oct 1, 2024
Turkey
ORLISTAT
25 KG Apr 2, 2024
Switzerland
orlistat 99% White powder orlistat
20000 MT Sep 5, 2023 Post an enquiry for this product